| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $52.0M | -17.7% | -22.4% |
| R&D Expense | $8.8M | -22.1% | -33.3% |
| SG&A Expense | $10.9M | -15.9% | -10.1% |
| Operating Income | -$68.9M | -438.4% | +53.6% |
| Pre-tax Income | -$72.7M | -682.9% | +49.9% |
| Net Income | -$72.7M | -682.9% | +49.9% |
| EPS (Basic) | -$1.36 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $44.0M | -6.0% | -34.4% |
| Accounts Receivable | $85.5M | -8.3% | -19.0% |
| Current Assets | $140.7M | -6.4% | -23.2% |
| Total Assets | $292.8M | -18.9% | -26.7% |
| Current Liabilities | $123.7M | -4.2% | -20.7% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | — |
| Capital Expenditures | $455K | — | — |
| Investing Cash Flow | -$13.0M | — | — |
| Financing Cash Flow | -$5.1M | — | — |
| Free Cash Flow | -$4.2M | — | — |
| -655.6% |
| +53.1% |
| EPS (Diluted) | -$1.36 | -655.6% | +53.1% |
| $214.6M |
| +0.2% |
| +0.7% |
| Total Liabilities | $297.5M | -1.6% | -9.8% |
| Stockholders' Equity | -$4.7M | -108.0% | -106.7% |